Biologics and Biosimilars: Do Physicians Understand the Differences?

Methods, results and conclusions.

Non-Medical Switching

Non-Medical Switching is cutting costs at the expense of patient health.

Medicare Part B Payment Demonstration

Infusion in Progress.

Cost-Focussed Clinical Pathways

Asthma’s Disproportionate Affects

Asthma disproportionately affects minorities, inner-city and low-income patients.

Strong Vaccination Policies

Strong vaccination policies protect patients and public health.

Tracing Side Effects to Their Source

Tracing side effects to their source requires a unique billing code for each biological medicine.

Que Es La Extrapolacion de Indicaciones?

Y debe ser permitida con los medicamentos biologicos?

CMS Oncology Care Model

Transparent Biosimilar Labeling

Physicians need clear data to safely prescribe biosimilar medications.

Back to Top